Memphasys Ltd MPHSF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- 3 / 3
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 28
- Website
- https://www.memphasys.com
Valuation
|
Metric
|
MPHSF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MPHSF
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.17 |
Interest Coverage | −11.24 |
Quick Ratio
MPHSF
Profitability
|
Metric
|
MPHSF
|
|---|---|
Return on Assets (Normalized) | −30.60% |
Return on Equity (Normalized) | −56.46% |
Return on Invested Capital (Normalized) | −29.86% |
Return on Assets
MPHSF
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Tgxzhxysv | Xvqc | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Bjjhxtzvs | Vksnx | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Klmvmzbl | Lgrtn | $97.8 Bil | |
MRNA
| Moderna Inc | Fjcxrckx | Vwg | $41.3 Bil | |
ARGX
| argenx SE ADR | Glqgvtwq | Ldxm | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Jfckzyrb | Dpnvh | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Xdwjmplf | Fvdwyr | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Sptbvmr | Rgxvww | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Wysphpps | Fdndm | $12.5 Bil | |
INCY
| Incyte Corp | Wpgfgss | Tfjgvkz | $11.6 Bil |